CITYSCAPE: Tiragolumab plus atezolizumab for non-small cell lung cancer ecancer 3:13 4 years ago 780 Далее Скачать
CITYSCAPE: 1L tiragolumab + atezolizumab vs placebo + atezolizumab in PD-L1-selected NSCLC VJOncology 1:12 2 years ago 209 Далее Скачать
Dr Melissa Johnson: Tiragolumab Plus Atezolizumab Improves Objective Response in CITYSCAPE Trial AJMCtv 2:03 4 years ago 489 Далее Скачать
Dr Melissa Johnson: Tiragolumab/Atezolizumab Potential New Treatment Option for NSCLC AJMCtv 4:05 4 years ago 514 Далее Скачать
Immuno-Oncology: A Deep Dive into Non-Small Cell Lung Cancer Citeline 1:01:11 5 years ago 482 Далее Скачать
Tiragolumab and atezolizumab in metastatic esophageal cancer VJOncology 0:39 3 years ago 588 Далее Скачать
ASCO Lung Cancer Roundtable - NSCLC - The CITYSCAPE Trial: Anti TIGIT & Immune Checkpoint Inhibitor GRACE - Global Resource for Advancing Cancer Education 8:35 4 years ago 647 Далее Скачать
Dr Chitresh Aggarwal | Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a 1L CRSF - Cancer Research and Statistic Foundation 6:04 1 year ago 40 Далее Скачать
Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer OncologyTube 2:21 4 years ago 48 Далее Скачать
FoRT 05-BEAT: comparing 1L atezolizumab vs atezolizumab + bevacizumab in PD-L1 high NSCLC VJOncology 1:06 2 years ago 64 Далее Скачать
Non-Small Cell Lung Cancer (NSCLC) Immunotherapy: Advancing Hope Society for Immunotherapy of Cancer 7:39 8 years ago 22 378 Далее Скачать
First-line atezolizumab plus chemotherapy improves survival in lung cancer patients infocusrx today 2:53 5 years ago 537 Далее Скачать
Dr. Melissa Johnson on Atezolizumab in Patients With NSCLC OncLive 1:50 8 years ago 2 104 Далее Скачать
Choosing Between Atezolizumab and Pembrolizumab in Lung Cancer Targeted Oncology 3:01 6 years ago 6 270 Далее Скачать